









Radial Optic Neurotomy: A New Surgical Approach for  
Glaucoma Treatment? 
 
Ruth E. Rosenstein¹, Nicolás Belforte¹ 
¹ Laboratory of Retinal Neurochemistry and Experimental Ophthalmology, Department of Human Biochemistry, School of Medicine, University of 
Buenos Aires/CEFyBO, CONICET, Buenos Aires, Argentina 
ABSTRACT 
Glaucoma is a leading cause of blindness worldwide, characterised by specific visual field defects due to the 
degeneration of retinal ganglion cells and damage to the optic nerve head (ONH). Elevated intraocular 
pressure (IOP) is the most important risk factor for glaucoma development. One of the clinical hallmarks of 
glaucomatous optic neuropathy is the excavation of the ONH, which consists of a progressive posterior 
displacement of the ONH surface and excavation of the pre-laminar tissues beneath the anterior-most 
aspect of the scleral canal, known as the anterior scleral ring. Radial optic neurotomy (RON) is a surgical 
technique that has been proposed for treating central retinal vein occlusion. While the original rationale of 
RON was the relief of increased tissue pressure within the optic nerve that results from occlusion of the 
central retinal vein, recent results are discussed here which suggest that by relaxing of the scleral ring of 
the prelaminar and laminar regions of the ONH, RON may alleviate the IOP-related connective tissue stress, 
and in turn, prevent the onset and reduce the progression of glaucomatous neuropathy.  
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INTRODUCTION  
Glaucoma is a leading cause of blindness worldwide, 
characterised by specific visual field defects due to the 
degeneration of retinal ganglion cells (RGCs) and damage to the 
optic nerve head (ONH). Elevated intraocular pressure (IOP) is 
the most important risk factor for the development of 
glaucoma. However, the underlying mechanisms that link 
elevated IOP to RGC death are still not fully understood. The 
ONH is of particular interest from a biomechanical perspective 
because it is a weak spot within an otherwise strong corneo-
scleral envelope.  
Several lines of evidence suggest that the lamina cribrosa is the 
principal site of RGC axonal insult in glaucoma [1]. The lamina 
cribrosa provides structural and functional support to the RGC 
axons as they pass from the relatively high-pressure 
environment in the eye to a low-pressure region in the 
retrobulbar cerebrospinal space [1]. One of the clinical 
hallmarks of glaucomatous optic neuropathy is the excavation 
of the ONH, which consists of a progressive posterior 
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displacement of the ONH surface and excavation of the 
prelaminar tissues beneath the anterior-most aspect of the 
scleral canal, known as the anterior scleral ring [2, 3]. A 
considerable body of literature characterised the classic 
posterior bowing and compression of the lamina cribrosa and 
excavation of the scleral canal wall beneath the opening in 
Bruch’s membrane in moderately and severely damaged 
glaucomatous eyes [4, 5]. Both plastic (permanent) and 
hypercompliant deformations of the lamina cribrosa and 
anterior scleral canal wall were described in monkey eyes with 
early experimental glaucoma [6], which have been confirmed 
by three-dimensional reconstructions of serially sectioned ONH 
and peripapillary sclera [7]. It has been postulated that damage 
to the ONH, the lamina cribrosa, and anterior scleral canal wall 
connective tissue plays a key role in glaucomatous neuropathy 
[8, 9].  
Radial optic neurotomy (RON) is a surgical technique that has 
been proposed for treating central retinal vein occlusion 
(CRVO). In 2001, Opremcak et al. [10] hypothesised that CRVO 
is a compartment-like syndrome which results from increased 
pressure on the central retinal vein (CRV) within the confined 
space of the scleral ring. To alleviate this neurovascular 
compression, the surgical dissection of the lamina cribrosa 
transvitreally via a radial incision on the nasal side of the optic 
nerve (ON) (i.e. radial optic neurotomy (RON)) was proposed as 
a surgical treatment to improve venous outflow. This group 
reported that 8 out of 11 patients showed an average 
improvement in visual acuity of five lines after a mean follow-
up of 9 months, whereas only two patients worsened [10]. 
Later on, the same group reported 117 cases treated with RON 
and 63 cases treated with RON plus an intravitreal 
triamcinolone injection, in which a gain of two or more lines 
was shown for 78% and 64% of patients, respectively [11, 12]. 
Improvements in visual acuity by RON have been confirmed by 
other investigators [13-17]. However, soon after the proposal 
of RON as a potential treatment for CRVO, a debate arose 
regarding whether the incision of the scleral outlet is a 
reasonable or dangerous procedure [18-21]. The potential risk 
of nerve fibre defects resulting in visual field loss has been 
particularly addressed by many authors [18, 19, 22]. Although 
the radial incision mode and site, as well as the use of 
microvitreoretinal blades specially designed for RON should 
minimise vessel and nerve fibre injury, surgical complications 
cannot be completely ruled out.  
 
HYPOTHESIS    
Since the connective tissues of the anterior scleral canal wall 
are permanently deformed at early stages of glaucoma [6], and 
considering that the ONH connective tissues are exposed to 
substantial levels of IOP-related stress/strain [3, 23, 24], it is 
postulated that by alleviating the constriction of the scleral 
outlet induced by ocular hypertension, RON could prevent 
and/or reduce glaucomatous damage.  
 
DISCUSSION  
Unravelling which are the most critical mechanisms involved in 
glaucoma is unlikely to be achieved by studies which are limited 
to the clinically observable changes to the retina and ONH that 
are seen in human glaucoma. Far more detailed and invasive 
studies are required, preferably in a readily available animal 
model. Recently, a model of glaucoma in rats has been 
developed through weekly injections of chondrotin sulphate 
(CS) in the eye anterior chamber, which mimics central features 
of human glaucoma [25]. Thus, this model could be a useful 
tool for understanding the pathogenic mechanisms involved in 
glaucomatous neuropathy, as well as for the development of 
new therapeutic strategies. Using this experimental model, it 
has been recently shown that RON, which shows no effects per 
se, decreases functional and histological alterations induced by 
chronic ocular hypertension in the rat eye [25]. Notably, the 
retinal protection induced by RON was independent of ocular 
hypertension, as shown by the fact that it did not affect the 
increase in IOP induced by CS injections. In hypertensive eyes, a 
significant decrease of retinal (electroretinogram) and visual 
pathway (visual evoked potentials) function is observed, 
whereas RON reduces these functional alterations [25]. 
Moreover, a significant loss of cells in the ganglion cell layer, 
and a decrease in Thy-1, NeuN and Brn3a (specific markers of 
RGCs) levels are observed in eyes injected with CS, whereas 
RON significantly preserves these parameters. Furthermore, 
RON preserves the ON structure in eyes with chronic ocular 
hypertension [25]. Therefore, these results indicate that RON 
reduces functional and histological alterations induced by 
experimental chronic ocular hypertension.  
As already mentioned, it is still under debate whether RON 
would be an adequate treatment or a dangerous procedure. 
Several surgical complications, such as laceration of the central 
retinal artery (CRA), further reductions in retinal blood flow, 
peripapillary retinal detachment from the RON site, ON fibre 
damage, visual field loss, and focal haemorrhagic pigment 
epithelium detachment, as well as chorioretinal 
neovascularisation from the RON site, were described [27- 31]. 
However, it has recently been shown that RON creates a defect 
in the lamina cribrosa and surrounding scleral ring of the optic 
nerve in normal rat eyes, without affecting the CRV and CRA, 
ocular functions, such as visual evoked potentials, and pupil 
light reflex, whereas a slight and transient decrease in the 
electroretinogram (ERG) is observed in eyes submitted to RON 
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[32]. Moreover, no significant vitreous haemorrhage or other 
serious complications are observed in vehicle- or CS-injected 
eyes submitted to RON, supporting the fact that, at least in rat 
eyes, RON is a safe procedure.  
The precise mechanisms responsible for the retinal protection 
against glaucomatous damage induced by RON remain to be 
established. For the past 30 years, discussion has focused on 
how RGC axons are damaged within the lamina cribrosa, and 
controversy has centred on whether IOP (the mechanical 
hypothesis) or ONH blood supply (the vascular hypothesis) is 
responsible for ONH axonal damage in this disease. However, 
consideration of the anatomy of the lamina cribrosa and 
peripapillary sclera suggests that the classic mechanical and 
vascular mechanisms of glaucomatous injury are inseparably 
intertwined [33]. For example, prior to structural damage, 
purely IOP-related stress could detrimentally affect the blood 
supply to the laminar segments of the axons through 
deformation of the capillary containing connective tissue 
structures. Also, IOP-related remodelling of the extracellular 
matrix of the laminar beams could limit the diffusion of 
nutrients to RGC axons in the ONH. Reciprocally, primary 
insufficiency in the blood supply to the laminar region could 
induce cell-mediated connective tissue changes that would 
serve to weaken the laminar beams, making them more prone 
to failure under previously safe levels of IOP-related mechanical 
stress [33]. Moreover, local damage at the lamina has been 
suggested to account for abnormal axonal transport in human 
and experimental glaucoma [34, 35]. Burgoyne et al. [3] have 
proposed that the ONH is a biomechanical structure; this 
paradigm assumes that IOP-related stress (force/cross-sectional 
area) and strain (local deformation of the tissues) are central 
determinants for the pathophysiology of the ONH tissues and 
their blood supply, particularly at high levels of IOP [33]. While 
the original rationale of RON was the relief of increased tissue 
pressure within the ON that results from occlusion of the CRV, 
the results of this study suggest that relaxation of the scleral 
ring of the prelaminar and laminar regions of the ONH may 
alleviate the IOP-related connective tissue stress, which, in 
turn, could prevent the onset and reduce glaucomatous 
neuropathy, presumably by counteracting ONH connective 
tissue damage, maintaining nutritional and oxygen supply, and 
axoplasmic transport at increased levels of IOP. It has been 
postulated that IOP-related stress and strain induce changes in 
the tissues that include not only alterations to the load-bearing 
connective tissues of the lamina cribrosa and the peripapillary 
sclera, but also to the cellular components of these tissues, 
including glial cells, endothelial cells, and pericytes, along with 
their basement membranes and the RGC axons in the ONH [6]. 
At present, it could not be ascertained whether there is a 
specific cellular type that is a target for RON, but this issue will 
be examined in the near future.  
A major weakness of the mentioned results relies on the 
differences between the rat and human eye. Although some 
results support the fact that the lamina cribrosa in the rat eye is 
thin and poorly developed [36], the rat eye was shown to be a 
good model for ophthalmological studies because its anatomy 
is similar to that of the human eye. In fact, it was shown that 
the rat ONH possess an identifiable lamina cribrosa with 
structural proteins nearly identical to that of the primate [37, 
38]. In contrast, the rabbit, chicken, and quail seem to be less 
adequate models to study the lamina cribrosa, the major 
problem being the myelinisation of the axons penetrating 
through the sparsely developed lamina cribrosa into the nerve 
fibre layer of the retina. This changes profoundly the situation 
of cell composition and mechanical reactivity in the ONH 
region. In addition, the retina from these species is avascular, 
which probably has a major influence on the ONH blood supply 
as well [39]. Thus, although care must be taken when 
extrapolating data generated in rodents to humans, the data of 
the current study provide evidence supporting the beneficial 
effects of RON on retinal and ON damage induced by chronic 
ocular hypertension. Due significance should be given to the 
fact that the ONH, a very delicate and crucial structure of the 
eye, is dealt with surgically. However, developments in 
techniques and technology could increase the margin of safety 
and efficacy of RON in humans, raising the hope that, in the 
future, benefits of RON against glaucomatous damage could 
outweigh the risks of this procedure. 
 
CONCLUSION 
Glaucoma, a leading cause of irreversible blindness, is a 
progressive neuropathy characterised by loss of vision as a 
result of RGC death and ON axon loss. Increased IOP is 
considered the major risk factor in glaucoma. Although the 
current management of glaucoma is mainly directed at the 
control of IOP, a therapy that prevents the death of RGCs and 
ON axon loss should be the main goal of treatment. Recent 
evidences obtained in a reliable experimental model of 
glaucoma in rats support the fact that RON, which does not 
affect IOP, not only prevents but also reduces functional and 
histological alterations provoked by chronic ocular 
hypertension. Thus, although further studies are required to 
evaluate the safety and efficacy of RON in humans, it is 
suggested that RON could be a new surgical tool helping the 
challenge faced by ophthalmologists treating glaucoma. 
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